Using metabolomics analysis, we found that specific metabolites, including linoleic acid, vaccenic acid, and ethyl pentadecanoate, were only identified in the culture supernatants of L
Continued therapy may be needed to sustain the benefits achieved over time
The ambivalence of clinical results may be closely related to several factors: (1) differences in patient staging, as positive trials predominantly included patients with early-stage PD, while negative trials encompassed a broader range of disease stages, where neuronal damage may have become irreversible in late-stage patients (Yoritaka et al., 2018)
These metabolites included markers that indicated: Decreases in oxidative stress (often high in children with autism) Beneficial changes in amino acids associated with the gut microbiome Improvements in neurotransmitters Positive changes in hormones including those related to stress Changes a type of lipid involved with the myelin sheath in nerves and the brain
Once the pharmacy accepts your order, the details of the pharmacy will be shared with you
Chitosan
